Integras Partners’s VanEck CLO ETF CLOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4M Buy
196,467
+28,258
+17% +$1.49M 5.74% 1
2026
Q1
$8.86M Buy
168,209
+7,685
+5% +$406K 5.82% 1
2025
Q4
$8.48M Buy
160,524
+5,397
+3% +$286K 6.85% 1
2025
Q3
$8.24M Buy
155,127
+73,269
+90% +$3.88M 6.66% 1
2025
Q2
$4.33M Sell
81,858
-60,096
-42% -$3.16M 4.36% 3
2025
Q1
$7.5M Buy
141,954
+7,295
+5% +$386K 6.77% 1
2024
Q4
$7.11M Buy
+134,659
New +$7.13M 6.07% 1

Other funds holding CLOI

Integras Partners's CLOI Position: Q2 2026 in Review

Integras Partners increased its VanEck CLO ETF (CLOI) stake by 17% in Q2 2026, buying an estimated $1.49M and bringing the position to 196,467 shares worth $10.4M. The position accounts for 5.74% of the portfolio, ranked #1.

Integras Partners first reported a position in CLOI in Q4 2024 and has held it in 7 quarters since. 198 funds tracked by Wall St. Rank hold CLOI as of Q2 2026.

  • Integras Partners held 196,467 shares of VanEck CLO ETF worth $10.4M as of Q2 2026.
  • Integras Partners bought 28,258 VanEck CLO ETF shares in Q2 2026, an estimated $1.49M.
  • VanEck CLO ETF made up 5.74% of Integras Partners's portfolio in Q2 2026, its #1 holding.
  • Integras Partners first reported a position in VanEck CLO ETF in Q4 2024 and has held it in 7 quarters since.
  • 198 funds tracked by Wall St. Rank held VanEck CLO ETF as of Q2 2026.

Based on Integras Partners's 13F filing for Q2 2026, filed 24 Jul 2026.